drugset / Trial / NCT03105661
Use of Impedance Cardiography to Decrease the Risk of Pre-eclampsia in Obese Patients
RandomizedParallel-groupOpen-labelPrevention
Summary
To determine if the use of impedance cardiography can identify appropriate medications for use in treating morbidly obese patients to decrease the risk of preeclampsia.
Timeline
- Start
- 2017-04-04
- Primary completion
- 2019-12-31
- Completion
- 2020-03-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Atenolol | Other / unclassified | 25 mg | — |
| Comparator | Labetalol | Small molecule | 200 mg | Oral |
| Comparator | Nifedipine | Other / unclassified | 60 mg | Oral |